TotalMarketCap

Polaryx Therapeutics

PLYXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$89.723 M

$1.80 +0.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Polaryx Therapeutics (PLYX) has a market capitalization of $89.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.98M

Loss-making

Shares outstanding

49,845,993

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #296Neonc TechnologiesNTHI$95.0M
  2. #297Perspective TherapeuticsCATX$90.4M
  3. #298Polaryx TherapeuticsPLYX$89.7M
  4. #299vTv TherapeuticsVTVT$86.4M
  5. #300Milestone PharmaceuticalsMIST$86.0M

What if Polaryx Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$566,482.32

Per share 314,712× higher

Bitcoin $1.53T

$30,651.37

Per share 17,029× higher

Apple $5.02T

$100,625.59

Per share 55,903× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Polaryx Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.